During the past decade, Matsusaka Municipal Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matsusaka Municipal Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matsusaka Municipal Hospital" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-small-Cell Lung" (1 trials), "EGFR Exon 19 Deletion" (1 trials) and "EGFR L858R" (1 trials). Many other conditions were trialed in "Matsusaka Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Matsusaka Municipal Hospital" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (3 trials), "Lazertinib" (3 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials) and "Amivantamab Intravenous" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matsusaka Municipal Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Matsusaka Municipal Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Matsusaka Municipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Matsusaka Municipal Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".